Skip to content

Brain Aging in Veterans (BRAVE) Training: A Cognitive Training Pilot Trial in Older Veterans With Traumatic Brain Injury

Cognitive Reserve and Training in Older Veterans With Traumatic Brain Injury: Study 2

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02561403
Enrollment
89
Registered
2015-09-28
Start date
2016-03-31
Completion date
2019-01-31
Last updated
2019-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

TBI (Traumatic Brain Injury)

Keywords

traumatic brain injury (TBI), aging, cognitive training, Cognitive Aging

Brief summary

The purpose of this study is to conduct a pilot trial investigating cognitive training in older Veterans with a history of traumatic brain injury (TBI) to assess training effects, acceptability of training to participants, and to explore whether other factors influence training effects.

Detailed description

A study of older Veterans (60-85 years old) who have 1) a history of repetitive mild TBI or at least one moderate TBI and 2) subjective cognitive complaints. Participants will be randomized to one of three conditions for 4 weeks: Project:Evolution (EVO) multitask video game, EVO words video game, or an assessment only control condition. Participants will complete assessment visits at baseline, post-intervention (1 month after baseline), and 3 months post-intervention (4 months after baseline).

Interventions

BEHAVIORALEVO multitask video game

Participants will play a multitasking game for 4 weeks

BEHAVIORALEVO words video game

Participants will play a word puzzle game for 4 weeks

Sponsors

VA Office of Research and Development
CollaboratorFED
San Francisco Veterans Affairs Medical Center
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
60 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

1. Ages 60-85 2. Have experienced more than one mild TBI or at least one moderate TBI over their lifetime 3. Have current cognitive problems based on self-report 4. Vision adequate to see test stimuli 5. Hearing adequate to understand the examiner 6. Fluent in English in order to understand task instructions 7. Demonstrate capacity to consent to participate in research 8. Mini-Mental Status Exam (MMSE) score ≥ 25

Exclusion criteria

1. History of penetrating brain injury 2. Active disabling neurological condition (e.g., stroke, brain tumor, multiple sclerosis) 3. History of severe psychiatric illness (i.e., schizophrenia, bipolar disorder, schizoaffective disorder) 4. Active drug use or active heavy alcohol use 5. History of severe TBI 6. History of a dementia diagnosis 7. Individuals who are physically unable to use an iPad for 30 minutes at a time per day will be excluded, such as individuals with debilitating arthritis or tremor

Design outcomes

Primary

MeasureTime frame
Acceptability based on participant ratingsAcceptability ratings assessed post-intervention (1-month after baseline)
Participant adherence to game playTotal adherence over the 4 week intervention phase
Change in cognitive functioning based on neurocognitive test batteryBaseline, post-intervention (1-month after baseline), and 3-months post-intervention (4-months after baseline)

Secondary

MeasureTime frame
Change in self-reported everyday cognitive functioning [Neuro-QOL (Quality of Life in Neurological Disorders) Cognitive Function inventory]Baseline, post-intervention (1-month after baseline), and 3-months post-intervention (4-months after baseline)
Change in EVO performance (EVO Monitor)Baseline, post-intervention (1-month after baseline), and 3-months post-intervention (4-months after baseline)
Change in everyday functioning [University of California San Diego (UCSD) Performance Based Skills Assessment (UPSA)]Baseline, post-intervention (1-month after baseline), and 3-months post-intervention (4-months after baseline)
Change in mood symptoms (Geriatric Depression Scale)Baseline, post-intervention (1-month after baseline), and 3-months post-intervention (4-months after baseline)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026